Voltage-dependent calcium channel alpha-2-delta subunits (alpha2delta subunits)

Voltage-dependent calcium channel alpha-2-delta (alpha2delta) subunits are essential auxiliary proteins that regulate the expression and function of high-voltage-activated calcium channels (CaV1 and CaV2 families) [1, 4]. These subunits, which exist in four isoforms (alpha2delta-1 through alpha2delta-4), are responsible for the trafficking of calcium channels from the endoplasmic reticulum to the plasma membrane and their localization at presynaptic terminals [3, 13]. By modulating calcium channel density and kinetics, they play a pivotal role in controlling the release of excitatory neurotransmitters and facilitating synaptogenesis [2, 8]. Pathologically, the alpha2delta-1 subunit is markedly upregulated in sensory neurons following nerve injury, a process that drives the development of neuropathic pain and central sensitization [7, 13]. The alpha2delta-1 and alpha2delta-2 subunits serve as the primary molecular targets for gabapentinoid drugs, such as gabapentin and pregabalin, which are widely used to treat chronic pain, epilepsy, and anxiety [5, 14]. These drugs exert their therapeutic effects by binding to the subunits and disrupting the trafficking of calcium channels, thereby reducing aberrant neuronal firing [4, 12].

Other names

alpha2delta subunitsVoltage-gated calcium channel auxiliary alpha2delta subunitsCACNA2D familyCalcium channel alpha-2-delta subunits

Gabapentinoid drugs bind to the alpha-2-delta-1 and alpha-2-delta-2 subunits, which inhibits the forward trafficking of voltage-gated calcium channels to the presynaptic membrane [3, 8]. This reduction in channel density at the synapse leads to decreased calcium-dependent release of excitatory neurotransmitters, such as glutamate and substance P, thereby attenuating neuronal hyperexcitability and providing analgesic and anticonvulsant effects [7, 12].